Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
Returns on capital
Apnimed, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Lawrence G. Miller | Founder & Vice Chair of the Board | USD 805.85K | 72 | 0 | <0.01% |
Dennis Molnar | President & COO | USD 645.8K | 57 | — | — |
Kevin Robert Lind | CEO & Director | — | 50 | 0 | <0.01% |
Michael Kelly | Chief Financial Officer | — | 51 | — | — |
Steven W. Spector | Chief Legal Officer & Head of Corporate Affairs | — | 61 | — | — |
Jennifer Patterson | Senior Vice President of Human Resources | — | — | — | — |
Leila Sylvain | Senior Manager of Administration | — | — | — | — |
John W. Cronin | Chief Medical Officer | — | 58 | — | — |
Luigi Taranto Montemurro | Co-Founder & Chief Scientific Officer | — | 47 | — | — |
Sean Johnston | Consulting Head of CMC | — | 68 | — | — |
Compensation is shown in the reported currency; data updated Nov 14, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 3, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$5.20M
Sells
0
$0.00
Net Transaction Value
+$5.20M
Net buying
Most Active
Morningside Venture Investments Ltd
1 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 3, 26Aug 3, 2026 | Morningside Venture Investments Ltd Direct | Buy | $5M$5,000,000.00 |
| Aug 3, 26Aug 3, 2026 | SEKHRI PAUL J Direct | Buy | $200K$200,000.00 |
Summary
Insiders reported 2 buys worth $5.20M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $5.20M. Morningside Venture Investments Ltd was the most active insider with 1 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Who does Apnimed, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about APMD's management, answered from reported figures.
Who manages APMD?
Apnimed, Inc. (APMD) lists 10 active executives. The top listed executive is Kevin Robert Lind, CEO & Director.
Are APMD insiders buying or selling?
Recent insider activity shows net buying of $25.54M.
Continue the stock analysis
Jump to another research area for this company.